University of Leicester
Browse

Timing of gestational diabetes diagnosis: A novel precision approach to hyperglycaemia in pregnancy?

Download (73.83 kB)
journal contribution
posted on 2024-07-04, 13:32 authored by Claire L Meek, David Simmons

Precision medicine has offered new opportunities to improve diagnosis, prognostication and management of type 1 diabetes and type 2 diabetes but is relatively unexplored in gestational diabetes. The results of the recent Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) trial suggests that the timing of diagnosis may identify clinically relevant subtypes of gestational diabetes.1 We, here, discuss the rationale, practicalities and translational opportunities of a precision approach to gestational diabetes, which incorporates the timing of diagnosis (‘early’ being before 20–24 weeks; ‘late’ being after 24 weeks).

Funding

Chewing the fat: gestational weight gain, gestational diabetes and pregnancy outcomes, a multi-site, randomised, controlled interventional study

Diabetes UK

Find out more...

European Foundation for the Study of Diabetes - Novo Nordisk Foundation (NNF19SA058974)

National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (IS-BRC-1215-20014)

History

Citation

Diabetic Medicine, 2023; 40:e15191

Author affiliation

College of Life Sciences Population Health Sciences

Version

  • AM (Accepted Manuscript)

Published in

Diabetic Medicine

Volume

40

Issue

11

Publisher

Wiley

issn

0742-3071

eissn

1464-5491

Acceptance date

2023-07-29

Copyright date

2023

Available date

2024-08-21

Spatial coverage

England

Language

en

Deposited by

Professor Claire Meek

Deposit date

2024-07-03

Rights Retention Statement

  • No

Usage metrics

    University of Leicester Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC